Israeli biotechnology company, BioGenCell, founded by Dr. Yael Porat and Prof. Michael Belkin, and developer of unique technology for using stem cells from the patient's own blood to treat microvascular diseases, has completed a $16 million seed round, led by Marius Nacht, Israel's largest private biotech investor.

The company later successfully treated another four, more-serious compassion cases. BioGenCell recently received FDA permission to continue to Phase II controlled, double-blind trials.

https://www.biogencell.net/

Netanya

Bio Gen Cell

Biogencell, Developer Of A Unique Platform For Treating Microvascular Disease, Has Completed A $16 Million Seed Round Led By Private Investor Marius Nacht

Biogencell, Developer Of A Unique Platform For Treating Microvascular Disease, Has Completed A $16 Million Seed Round Led By Private Investor Marius Nacht

Description

Company Information

FundzWatch™ Score

Buyer Intent Analysis

Funding Insights

Biogencell, Developer Of A Unique Platform For Treating Microvascular Disease, Has Completed A $16 Million Seed Round Led By Private Investor Marius Nacht

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

FundzWatch™ Score

Buyer Intent Analysis

Funding Insights

Company Information